The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands

Aklilu Melese Mengesha

doi:doi:10.11648/j.ijbc.20220701.11

| Peer-Reviewed

The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands

Aklilu Melese Mengesha

Published in International Journal of Bioorganic Chemistry (Volume 7, Issue 1)

Received: 1 February 2022 Accepted: 24 February 2022 Published: 28 February 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The widespread usage of antibiotics in recent years has resulted in a surge in drug‑resistant bacteria resistant to a variety of medications. The identification of innovative and potent molecules against new targets is critical to combating the worrisome problem of microbial resistance to antibiotics. Numerous transition metal mixed ligand complexes have been explored as a result of this, with promising results. Because transition metals have different oxidation states and can interact with a variety of ligands, they play an essential role in medical inorganic chemistry. Metals' high activity has led to the recent creation of metal‑based pharmaceuticals that are being explored as viable candidates for pharmacological and therapeutic purposes. This review focuses on research conducted over the last few decades that has sought to possess biological applications such as antimicrobial, antifungal, and antibacterial activities of synthetic mixed ligand transition metal complexes, and it focuses primarily on a small number of transition metal mixed ligand complexes such as Mn (II), Co(II), Cu(II), and Zn(II), Ru(III) that contain 1,10-Phenanthroline as a major ligand The majority of this article is devoted to nitrogen donor ligands that chelate transition metals and are employed in metallodrugs.

Published in	International Journal of Bioorganic Chemistry (Volume 7, Issue 1)
DOI	10.11648/j.ijbc.20220701.11
Page(s)	1-10
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

1,10-phenanthriline, Mixed Ligand Complexes, Biological Activities

References

[1]	Agwara, M. O., Ndifon, P. T., Ndosiri, N. B., Paboudam, A. G., Yufanyi, D. M. and Mohamadou, A., 2010. Synthesis, characterization, and antimicrobial activities of Cobalt (ii), copper (ii), and zinc (ii) mixed-ligand complexes containing 1,10-Phenanthroline and 2,2’-bipyridine. Bulletin of the Chemical Society of Ethiopia, 24 (3), 383-389.
[2]	Abdolmaleki, S., Ghadermazi, M., Fattahi, A., Shokraii, S., Alimoradi, M., Shahbazi, B. and Judy Azar, A. R., 2017. Synthesis, crystallographic and spectroscopic studies, and evaluation as antimicrobial and cytotoxic agents of a novel mixed‑ligand nickel (II) complex. Journal of Coordination Chemistry, 70 (8), pp. 1406-1423.
[3]	Paison, F., Su, B., Pan, D., Yan, T. and Wu, J., 2020. The Study of Biological Activities of Various Mixed Ligand Complexes of Nickel (II). Austin Biochem, 5 (1), p. 1025.
[4]	Abebe, A., Bayeh, Y., Belay, M., Gebretsadik, T., Thomas, M. and Linert, W., 2020. Mono and binuclear cobalt (II) mixed ligand complexes containing 1,10-Phenanthroline and adenine using 1,3-diaminopropane as a spacer synthesis, characterization, and antibacterial activity investigations. Future Journal of Pharmaceuti-cal Sciences, 6, pp. 1-9.
[5]	Abebe, A. and Hailemariam, T., 2016. Synthesis and assessment of antibacterial activities of ruthenium (III) mixed ligand complexes containing 1,10-Phenanthroline and guanide. Bioinorganic chemistry and applications, 2016.
[6]	Abebe, A., Kendie, M. and Tigineh, G. T., 2021. Mono-and Binuclear Cobalt (II) Mixed Ligand Complexes of 2,2’-Bipyridine and ethylenediamine: Synthesis, Characterization, and biological application. 12 (2), pp1962-1973.
[7]	Ndosiri, N. B., Agwara, M. O., Paboudam, A. G., Ndifon, P. T., Yufanyi, D. M. and Amah, C., 2013. Synthesis, characterization, and antifungal activities of Mn (II), Co (II), Cu(II), and Zn (II) mixed-ligand complexes containing 1,10-Phenanthroline and 2, 2-bipyridine. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 4 (1), pp. 386-397.
[8]	Ndifon, P. T., Moise, A. O., Julius, N. N., Mbom, Y. D., Awawou, P. G. and Lynda, N. D., 2010. Synthesis, Characterisation, and Antimicrobial Activities of Copper (II) and Zinc (II) Complexes of Schiff Bases derived from Amino Acids and 1,10-Phenanthroline Mixed Ligands. Research Journal of Chemistry and Environment, 14 (2), pp. 50-54.
[9]	Naik, A. D., Annigeri, S. M., Gangadharmath, U. B., Revankar, V. K., Mahale, V. B. and Reddy, V. K., 2002. Anchoring mercapto-triazoles on dicarbonyl backbone to assemble novel binucleating acyclic SNONS compartmental ligands. Indian J Chem 41A: 2046-2053.
[10]	Selvaganapathy, M. and Raman, N., 2016. Pharmacological activity of a few transition metal complexes: a short review. Journal of Chemical Biology & Therapeutics, 1 (2), pp. 1-17.
[11]	Zeglis, B. M., Pierre, V. C. and Barton, J. K., 2007. Metallo-intercalators and metallo-insertors. Chemical Communications, (44), pp. 4565-4579.
[12]	Erkkila, K. E., Odom, D. T. and Barton, J. K., 1999. Recognition and reaction of metallointercalators with DNA. Chemical Reviews, 99 (9), pp. 2777-2796.
[13]	Bayeh, Y., Abebe, A., Thomas, M. and Linert, W., 2019. Synthesis, characterization, and antimicrobial activities of new mixed ligand complexes of copper (II) with 1,10-Phenanthroline and thymine. Journal of Transition Metal Complexes, 2, pp. 1-6.
[14]	Sreekanth, B., Krishnamurthy, G., Naik, H. B., Vishnuvardhan, T. K., Vinaykumar, B. and Sharath, N., 2011. Synthesis, DNA binding, and oxidative cleavage studies of Fe (II) and Co (III) complexes containing bioactive ligands. Nucleotides, and Nucleic Acids, 30 (2), pp. 83-96.
[15]	Kasuga, N. C., Sekino, K., Koumo, C., Shimada, N., Ishikawa, M. and Nomiya, K., 2001. Synthesis, structural characterization and antimicrobial activities of 4‑and 6‑coordinate nickel (II) complexes with three thiosemicarbazones and semicarbazone ligands. Journal of inorganic biochemistry, 84 (1-2), pp. 55-65.
[16]	Raman, N. and Sobha, S., 2010. Synthesis, characterization, DNA interaction, and antimicrobial screening of isatin-based polypyridyl mixed ligand Cu(II) and Zn (II) complexes. Journal of the Serbian Chemical Society, 75 (6), pp. 773-788.
[17]	Mohapatra, B. and Verma, S., 2013. Crystal engineering with modified 2-aminopurine and group 12 metal ions. Crystal growth & design, 13 (7), pp. 2716-2721.
[18]	Patel, D. K., Domínguez-Martín, A., del Pilar Brandi-Blanco, M., Choquesillo-Lazarte, D., Nurchi, V. M. and Niclós-Gutiérrez, J., 2012. Metal ion binding modes of hypoxanthine and xanthine versus the versatile behaviour of adenine. Coordination Chemistry Reviews, 256 (1-2), pp. 193-211.
[19]	Goo, Y. R., Maity, A. C., Cho, K. B., Lee, Y. M., Seo, M. S., Park, Y. J., Cho, J., Nam, W., 2015. Tuning the reactivity of chromium (III)-superoxo species by coordinating axial ligands. Inorganic Chemistry 54 (21), 10513-10520.
[20]	Abbas, B. F., Kamel, B. A. and Khamais, W. M., 2019. Preparation, diagnosis, biological activity, and theoretical studies of some mixed drug complexes. The Scientific World Journal, 2019.
[21]	Bodkhe, A. S., Patil, S. S. and Shaikh, M. M., 2012. Synthesis, characterization, and antibacterial studies on mixed ligand copper complexes with polydentate ligands. Acta poloniae pharmaceutica, 69 (5), pp. 871-877.
[22]	Devi, J. and Batra, N., 2015. Synthesis, characterization, and antimicrobial activities of mixed ligand transition metal complexes with isatin monohydrazone Schiff base ligands and heterocyclic nitrogen base. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 135, pp. 710-719.
[23]	Jha, A., Murthy, Y. L. N., Sanyal, U. and Durga, G., 2012. Rapid synthesis, characterization, anticancer, and antimicrobial activity studies of substituted thiadiazoles and their dinucleating ligand‑metal complexes. Medicinal Chemistry Research, 21 (9), pp. 2548-2556.
[24]	Moustafa, I. M. I. and Magda, H., 2017. Synthesis, spectroscopic studies, and biological evaluation of Co (II), Ni (II), Cu(II) and Zr (IV) complexes of azo dye and thiamine hydrochloride as antimicrobial agents. Mod Chem Appl, 5 (202), p. 2.
[25]	Tigineh, G. T., Abiye, M., Melese, A. and Abebe, A., 2021. Synthesis, structural investigations, and in vitro biological activity of Co (II) and Fe (III) mixed ligand complexes of 1,10-Phenanthroline and 2,2′-bipyridine. Chemical Biology & Drug Design.
[26]	Sabale, P. M., Kaur, P., Patel, Y., Patel, J. and Patel, R., 2012. Metalloantibiotics in therapy: an overview. J Chem Pharm Res, 4 (11), pp. 4921-4936.
[27]	Muthusamy, S. and Natarajan, R., 2016. Pharmacological activity of a few transition metal complexes: A short review. J. Chem. Bio. Ther, 1 (2), pp. 1-17.
[28]	Abebe, A., Atlabachew, M., Liyew, M. and Ferede, E., 2018. Synthesis of organic salts from 1,10-Phenanthroline for biological applications. Cogent Chemistry, 4 (1), pp. 1476077.
[29]	Tamiru, G., Abebe, A., Abebe, M. and Liyew, M., 2019. Synthesis, structural investigation, and biological application of new mono-and binuclear cobalt (II) mixed‑ligand complexes containing 1,10‑Phenanthroline, acetamide, and ethylenediamine. Ethiopian Journal of Science and Technology, 12 (1), pp. 69-91.
[30]	Feng, G., Shi, Y., Zhang, L., Shi, R., Huang, W. and Wang, R., 2017. Air-oxidation from sulfur to sulfone-bridged Schiff base macrocyclic complexes showing enhanced antimicrobial activities. Scientific reports, 7 (1), pp. 1-6.
[31]	Tsapkov, V. I., Buracheeva, S. A., Byrke, M. S. and Gulya, A. P., 2005. Synthesis and antimicrobial activity of coordination compounds of copper with substituted salicylaldehyde thiosemicarbazones. Pharmaceutical Chemistry Journal, 39 (6), pp. 313-315.
[32]	Bindu, P., Kurup, M. R. P. and Satyakeerty, T. R., 1998. Epr, cyclic voltammetric and biological activities of copper (II) complexes of salicylaldehyde N (4)-substituted thiosemicarbazone and heterocyclic bases. Polyhedron, 18 (3-4), pp. 321-331.
[33]	Thebo, A. A., Nahyoon, N. A., Phulpoto, S. N., Khan, A., Shah, S. A., Ali, S. and Thebo, K. H., 2017. Synthesis, Characterization, and Biological Evaluation of Copper (ii) Metal Complex with 1,10-Phenanthroline. Organic & Medicinal Chemistry International Journal, 2 (1), pp. 8-12.
[34]	Ferrari, M. B., Capacchi, S., Pelosi, G., Reffo, G., Tarasconi, P., Albertini, R., Pinelli, S. and Lunghi, P., 1999. Synthesis, structural characterization, and biological activity of helicin thiosemicarbazone monohydrate and a copper (II) complex of salicylaldehyde thiosemicarbazone. Inorganica Chimica Acta, 286 (2), pp. 134-141.
[35]	Patil, B. G., Havinale, B. R., Shallom, J. M. and Chitnis, M. P., 1989. Synthesis and spectroscopic studies of potential antitumor copper (II) complexes with 5-phenylazo‑3‑methoxy salicylidene thiosemicarbazone and N4 substituted thiosemicarbazones. Journal of inorganic biochemistry, 36 (2), pp. 107-113.
[36]	Gałczyńska, K., Drulis-Kawa, Z. and Arabski, M., 2020. Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes. Molecules, 25 (15), pp. 3492.
[37]	Abebe, A., Sendek, A., Ayalew, S. and Kibret, M., 2017. Copper (II) mixed‑ligand complexes containing 1,10-Phenanthroline, adenine and thymine: Synthesis, characterization andantibac-terial activities. Chemistry International, 3 (3), pp. 230-239.

Cite This Article

Plain Text BibTeX RIS

APA Style

Aklilu Melese Mengesha. (2022). The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. International Journal of Bioorganic Chemistry, 7(1), 1-10. https://doi.org/10.11648/j.ijbc.20220701.11

Copy | Download

ACS Style

Aklilu Melese Mengesha. The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. Int. J. Bioorg. Chem. 2022, 7(1), 1-10. doi: 10.11648/j.ijbc.20220701.11

Copy | Download

AMA Style

Aklilu Melese Mengesha. The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. Int J Bioorg Chem. 2022;7(1):1-10. doi: 10.11648/j.ijbc.20220701.11

Copy | Download

@article{10.11648/j.ijbc.20220701.11,
  author = {Aklilu Melese Mengesha},
  title = {The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands},
  journal = {International Journal of Bioorganic Chemistry},
  volume = {7},
  number = {1},
  pages = {1-10},
  doi = {10.11648/j.ijbc.20220701.11},
  url = {https://doi.org/10.11648/j.ijbc.20220701.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijbc.20220701.11},
  abstract = {The widespread usage of antibiotics in recent years has resulted in a surge in drug‑resistant bacteria resistant to a variety of medications. The identification of innovative and potent molecules against new targets is critical to combating the worrisome problem of microbial resistance to antibiotics. Numerous transition metal mixed ligand complexes have been explored as a result of this, with promising results. Because transition metals have different oxidation states and can interact with a variety of ligands, they play an essential role in medical inorganic chemistry. Metals' high activity has led to the recent creation of metal‑based pharmaceuticals that are being explored as viable candidates for pharmacological and therapeutic purposes. This review focuses on research conducted over the last few decades that has sought to possess biological applications such as antimicrobial, antifungal, and antibacterial activities of synthetic mixed ligand transition metal complexes, and it focuses primarily on a small number of transition metal mixed ligand complexes such as Mn (II), Co(II), Cu(II), and Zn(II), Ru(III) that contain 1,10-Phenanthroline as a major ligand The majority of this article is devoted to nitrogen donor ligands that chelate transition metals and are employed in metallodrugs.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands
AU  - Aklilu Melese Mengesha
Y1  - 2022/02/28
PY  - 2022
N1  - https://doi.org/10.11648/j.ijbc.20220701.11
DO  - 10.11648/j.ijbc.20220701.11
T2  - International Journal of Bioorganic Chemistry
JF  - International Journal of Bioorganic Chemistry
JO  - International Journal of Bioorganic Chemistry
SP  - 1
EP  - 10
PB  - Science Publishing Group
SN  - 2578-9392
UR  - https://doi.org/10.11648/j.ijbc.20220701.11
AB  - The widespread usage of antibiotics in recent years has resulted in a surge in drug‑resistant bacteria resistant to a variety of medications. The identification of innovative and potent molecules against new targets is critical to combating the worrisome problem of microbial resistance to antibiotics. Numerous transition metal mixed ligand complexes have been explored as a result of this, with promising results. Because transition metals have different oxidation states and can interact with a variety of ligands, they play an essential role in medical inorganic chemistry. Metals' high activity has led to the recent creation of metal‑based pharmaceuticals that are being explored as viable candidates for pharmacological and therapeutic purposes. This review focuses on research conducted over the last few decades that has sought to possess biological applications such as antimicrobial, antifungal, and antibacterial activities of synthetic mixed ligand transition metal complexes, and it focuses primarily on a small number of transition metal mixed ligand complexes such as Mn (II), Co(II), Cu(II), and Zn(II), Ru(III) that contain 1,10-Phenanthroline as a major ligand The majority of this article is devoted to nitrogen donor ligands that chelate transition metals and are employed in metallodrugs.
VL  - 7
IS  - 1
ER  -

Copy | Download

Author Information

Aklilu Melese Mengesha

Department of Chemistry, College of Natural and Computational Sciences, Kebridehar University, Kebridehar, Ethiopia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Aklilu Melese Mengesha. (2022). The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. International Journal of Bioorganic Chemistry, 7(1), 1-10. https://doi.org/10.11648/j.ijbc.20220701.11

Copy | Download

ACS Style

Aklilu Melese Mengesha. The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. Int. J. Bioorg. Chem. 2022, 7(1), 1-10. doi: 10.11648/j.ijbc.20220701.11

Copy | Download

AMA Style

Aklilu Melese Mengesha. The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands. Int J Bioorg Chem. 2022;7(1):1-10. doi: 10.11648/j.ijbc.20220701.11

Copy | Download

@article{10.11648/j.ijbc.20220701.11,
  author = {Aklilu Melese Mengesha},
  title = {The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands},
  journal = {International Journal of Bioorganic Chemistry},
  volume = {7},
  number = {1},
  pages = {1-10},
  doi = {10.11648/j.ijbc.20220701.11},
  url = {https://doi.org/10.11648/j.ijbc.20220701.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijbc.20220701.11},
  abstract = {The widespread usage of antibiotics in recent years has resulted in a surge in drug‑resistant bacteria resistant to a variety of medications. The identification of innovative and potent molecules against new targets is critical to combating the worrisome problem of microbial resistance to antibiotics. Numerous transition metal mixed ligand complexes have been explored as a result of this, with promising results. Because transition metals have different oxidation states and can interact with a variety of ligands, they play an essential role in medical inorganic chemistry. Metals' high activity has led to the recent creation of metal‑based pharmaceuticals that are being explored as viable candidates for pharmacological and therapeutic purposes. This review focuses on research conducted over the last few decades that has sought to possess biological applications such as antimicrobial, antifungal, and antibacterial activities of synthetic mixed ligand transition metal complexes, and it focuses primarily on a small number of transition metal mixed ligand complexes such as Mn (II), Co(II), Cu(II), and Zn(II), Ru(III) that contain 1,10-Phenanthroline as a major ligand The majority of this article is devoted to nitrogen donor ligands that chelate transition metals and are employed in metallodrugs.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - The Study of Antimicrobial Activities of Various Transition Metal Mixed Ligand Complexes Containing 1,10-Phenanthroline with Any Other Ligands
AU  - Aklilu Melese Mengesha
Y1  - 2022/02/28
PY  - 2022
N1  - https://doi.org/10.11648/j.ijbc.20220701.11
DO  - 10.11648/j.ijbc.20220701.11
T2  - International Journal of Bioorganic Chemistry
JF  - International Journal of Bioorganic Chemistry
JO  - International Journal of Bioorganic Chemistry
SP  - 1
EP  - 10
PB  - Science Publishing Group
SN  - 2578-9392
UR  - https://doi.org/10.11648/j.ijbc.20220701.11
AB  - The widespread usage of antibiotics in recent years has resulted in a surge in drug‑resistant bacteria resistant to a variety of medications. The identification of innovative and potent molecules against new targets is critical to combating the worrisome problem of microbial resistance to antibiotics. Numerous transition metal mixed ligand complexes have been explored as a result of this, with promising results. Because transition metals have different oxidation states and can interact with a variety of ligands, they play an essential role in medical inorganic chemistry. Metals' high activity has led to the recent creation of metal‑based pharmaceuticals that are being explored as viable candidates for pharmacological and therapeutic purposes. This review focuses on research conducted over the last few decades that has sought to possess biological applications such as antimicrobial, antifungal, and antibacterial activities of synthetic mixed ligand transition metal complexes, and it focuses primarily on a small number of transition metal mixed ligand complexes such as Mn (II), Co(II), Cu(II), and Zn(II), Ru(III) that contain 1,10-Phenanthroline as a major ligand The majority of this article is devoted to nitrogen donor ligands that chelate transition metals and are employed in metallodrugs.
VL  - 7
IS  - 1
ER  -

Copy | Download